Trevisani F - Search Results

1

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.

Stefanini B, Bucci L, Santi V, Reggidori N, Rampoldi D, Lani L, Granito A, Sangiovanni A, Cabibbo G, Farinati F, Campani C, Foschi FG, Svegliati-Baroni G, Raimondo G, Gasbarrini A, Mega A, Biasini E, Sacco R, Morisco F, Caturelli E, Vidili G, Azzaroli F, Giannini EG, Rapaccini GL, Brunetto MR, Masotto A, Nardone G, Di Marco M, Magalotti D, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Stefanini B, et al. Among authors: trevisani f. Dig Liver Dis. 2022 Nov;54(11):1563-1572. doi: 10.1016/j.dld.2022.07.003. Epub 2022 Jul 27. Dig Liver Dis. 2022. PMID: 35906166

2

Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Trevisani F, D'Intino PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, Grazi GL, Gozzetti G, Gasbarrini G, Bernardi M. Trevisani F, et al. Cancer. 1995 May 1;75(9):2220-32. doi: 10.1002/1097-0142(19950501)75:9<2220::aid-cncr2820750906>3.0.co;2-4. Cancer. 1995. PMID: 7536121

3

Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosis.

Bernardi M, Gasbarrini A, Trevisani F, Caraceni P, De Collibus C, Colantoni A, Andreone P, Cursaro C, Ligabue A, Gasbarrini G. Bernardi M, et al. Among authors: trevisani f. J Hepatol. 1995 Jan;22(1):10-6. doi: 10.1016/0168-8278(95)80253-3. J Hepatol. 1995. PMID: 7751575

4

Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.

Bernardi M, Rimondi A, Gasbarrini A, Trevisani F, Caraceni P, Legnani C, Palareti G, Gasbarrini G. Bernardi M, et al. Among authors: trevisani f. J Hepatol. 1994 Feb;20(2):289-95. doi: 10.1016/s0168-8278(05)80071-6. J Hepatol. 1994. PMID: 8006409

5

Hepatorenal disorders: role of the renin-angiotensin-aldosterone system.

Bernardi M, Trevisani F, Gasbarrini A, Gasbarrini G. Bernardi M, et al. Among authors: trevisani f. Semin Liver Dis. 1994 Feb;14(1):23-34. doi: 10.1055/s-2007-1007295. Semin Liver Dis. 1994. PMID: 8016659 Review. No abstract available.

6

Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients.

Trevisani F, D'Intino PE, Grazi GL, Caraceni P, Gasbarrini A, Colantoni A, Stefanini GF, Mazziotti A, Gozzetti G, Gasbarrini G, Bernardi M. Trevisani F, et al. Cancer. 1996 Jun 1;77(11):2223-32. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2223::AID-CNCR7>3.0.CO;2-Q. Cancer. 1996. PMID: 8635088

7

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Trevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnù L, Zoli M, Grazi GL, Del PP, Di N, Bernardi M; Italian Liver Cancer Group. Trevisani F, et al. Am J Gastroenterol. 2002 Mar;97(3):734-44. doi: 10.1111/j.1572-0241.2002.05557.x. Am J Gastroenterol. 2002. PMID: 11922571

8

Evidence of oxidative imbalance in long-term liver transplant patients.

Trevisani F, Caraceni P, Simoncini M, Micati M, Domenicali M, Dazzani F, Zambruni A, Stefanelli C, Grazi G, Nardo B, Guarnieri C, Bernardi M. Trevisani F, et al. Dig Liver Dis. 2002 Apr;34(4):279-84. doi: 10.1016/s1590-8658(02)80148-7. Dig Liver Dis. 2002. PMID: 12038812

9

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.

Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M; Italian Liver Cancer (ITALICA) group. Trevisani F, et al. Am J Gastroenterol. 2004 Aug;99(8):1470-6. doi: 10.1111/j.1572-0241.2004.30137.x. Am J Gastroenterol. 2004. PMID: 15307862

10

High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.

Andreone P, Gramenzi A, Cursaro C, Biselli M, Cammà C, Trevisani F, Bernardi M. Andreone P, et al. Among authors: trevisani f. J Viral Hepat. 2004 Sep;11(5):439-42. doi: 10.1111/j.1365-2893.2004.00564.x. J Viral Hepat. 2004. PMID: 15357649 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

363 results

Search Page